Technology News and Research

RSS

Sevocity's EHR v11.1 achieves CCHIT 2011 certification

Sevocity, the leader in cloud-based Electronic Health Records, today announced that Sevocity v11.1 has achieved full certification through the Certification Commission for Health Information Technology (CCHIT) and is a CCHIT Certified 2011 Ambulatory EHR.

12 Jul 2011

Ipsen, Salk Institute renew Life Sciences Program

Ipsen and The Salk Institute for Biological Studies announced today that they are renewing the Ipsen Life Sciences Program at The Salk Institute.

12 Jul 2011

Gilead announces expansion of global access program for HIV medications

Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS.

12 Jul 2011

KiDA to host Third Annual Summit on Autism

Kids Institute for Development and Advancement (KiDA), a premier center for autism treatment, hosts its Third Annual Summit on Autism Saturday, September 17, 2011, at the University of California, Irvine's Bren Events Center, beginning at 8:00 am.

12 Jul 2011

Poisonous shrub extract may act as natural painkiller

An extract of the poisonous shrub Jatropha curcas acts as a strong painkiller and may have a mode of action different from conventional analgesics, such as morphine and other pharmaceuticals.

12 Jul 2011

Battle lines drawn in the CT dose reduction arena

Over the past ten years, Computed Tomography (CT) vendors have been in a fierce race to capitalise on the trend for multi-slice CT equipment. However, in the last three years, increasing concerns over radiation exposure from CT examinations have driven a focus on dose-reduction, and CT product development has followed suit. As battle lines are drawn in the dose-reduction arena, InMedica (www.in-medica.com) analyses the competition for CT slices in its new report “The World Market for CT and PET-CT Equipment.” Importantly, what will this mean for dose-reduction?

12 Jul 2011

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

genOway and bluebird bio report today genOway acquisition of an exclusive worldwide license for the RMCE technology (developed at the Massachusetts Institute of Technology) in the field of genetically modified rodents.

12 Jul 2011

Biomet net sales increase 1% to $2.732 billion for fiscal year 2011

Biomet, Inc. announced today preliminary financial results for its fourth quarter and fiscal year ended May 31, 2011.

12 Jul 2011

Study: 82% of Georgia hospitals do not offer palliative care services

Hospitals across the nation are increasingly implementing palliative care programs to help patients manage the physical and emotional burdens of serious illnesses, but a new University of Georgia study finds that 82 percent of the state's hospitals do not offer palliative care services.

12 Jul 2011

BioAlliance receives European patent for Livatag to treat primary liver cancer

BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announces the grant of a European patent protecting its Transdrug nanotechnology.

12 Jul 2011

New ‘world-first’ Malaria vaccine in the pipeline

Australian researchers have potentially created a ‘world-first’ malaria vaccine that could save millions of lives. According to Professor Michael Good, of Griffith University in Queensland, his team have found a way to completely protect mice against multiple strains of malaria. The team hopes to begin human trials over the next year to see if it produces a similar response.

12 Jul 2011

Viewpoints: N.Y. health exchange stalemate; Dick Cheney's heart; vaccine debate refuses to die

Just in case you hadn't noticed, no one has elected Grover Norquist to anything. Still, he looms as a major obstacle to Congress reaching a deficit-reduction agreement needed to raise the federal debt ceiling. … what's revealing about Norquist's passionate advocacy against taxes is that it virtually ignores the main causes of bigger government: Social Security and Medicare.

12 Jul 2011

Toumaz announces JV for newly approved ‘digital plaster’

Toumaz Limited (AIM: TMZ,) has established a new joint venture with Dr. Patrick Soon-Shiong’s company California Capital Equity LLC (‘CCE’), to expand the commercialisation and distribution of the Sensium™ Digital Plaster. The joint venture, which is named “Toumaz US LLC”, will be headquartered in San Diego, California, and will sell and distribute the Sensium™ Digital Plaster in North America and Worldwide.

11 Jul 2011

Novis opens fifth office location in San Luis Obispo

Novis Pharmaceuticals, a leading distributor of critical care products, has officially opened their fifth office location in San Luis Obispo, California. With more than 30 years of industry experience, Novis' aggressive plan to expand their national presence continues to move forward with news of this location opening. Placed strategically between San Francisco and Los Angeles, Novis believes this will help capture parts of the regional market.

11 Jul 2011

Parallels, Microsoft partner to deliver complete cloud automation solution for health community

At the Microsoft World Wide Partner conference, Parallels today announced a two-year strategic relationship with Microsoft to deliver a complete cloud automation solution focused on meeting the needs of the health industry around the world.

11 Jul 2011

Evolution Benefits and Lighthouse1 merge to create Evolution1

Evolution Benefits and Lighthouse1 announced today that they have completed merging their companies to create Evolution1. Evolution1 offers the nation's most comprehensive electronic payment, on-premise and cloud computing solutions for the administration of flexible spending accounts (FSAs), health savings accounts (HSAs), health reimbursement accounts (HRAs), VEBAs, wellness and transit plans.

11 Jul 2011

RyMed's InVision-Plus Intraluminal Protection System effective against catheter-related bloodstream infections

Denise Macklin, BSN, RNC, representing the research team of Dr. Cynthia C. Chernecky Ph.D., RN, AOCN, FAAN, Dr. Jennifer Waller, Ph.D., both from Georgia Health Sciences University; and Dr. William Jarvis M.D., Jason & Jarvis Associates, exhibited a poster at the recent APIC 2011 (Association for Professionals in Infection Control and Epidemiology) conference in Baltimore, titled "Clinical Comparisons of Split Septum, Positive and Negative Mechanical Valve Intravenous Connectors to an Intraluminal Protection Connector on Infection Rates."

11 Jul 2011

Research validates SpinalCyte's core technology to regrow the spinal disc

SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the publication of its research completed with Rice University, titled, "Chondrogenic Differentiation of Neonatal Human Dermal Fibroblasts Encapsulated in Alginate Beads with Hydrostatic Compression Under Hypoxic Conditions in the Presence of Bone Morphogenetic Protein-2".

11 Jul 2011

FDA clears TearScience's LipiFlow Thermal Pulsation System for evaporative dry eye

TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its LipiFlow Thermal Pulsation System for the treatment of meibomian gland dysfunction (MGD), also known as evaporative dry eye.

11 Jul 2011

FDA-approved Zuplenz oral soluble film now available for licensing to new commercial partners

MonoSol Rx, a specialty pharmaceutical company and the developers of the PharmFilm technology platform, in collaboration with APR Applied Pharma Research s.a. of Switzerland, announced today that its FDA-approved anti-emetic Zuplenz (Ondansetron) oral soluble film is available for licensing to new commercial partners.

11 Jul 2011